Table 2.
Treatments and outcome of patients with NMDAR encephalitis before rituximab (RTX).
| No. | Tumor | Symptom onset until start of immunotherapy, (d) | Immunotherapy | MRS at diagnosis | MRS after aforementioned therapy | Treatment response |
|---|---|---|---|---|---|---|
| 1 | Negative | 20 | Steroids, IVIg cyclophosphamide | 5 | 3 | Partial |
| 2 | Negative | 7 | Steroids, IVIg | 5 | 4 | Partial |
| 3 | Negative | 14 | Steroids, IVIg | 5 | 4 | Partial |
| 4 | Negative | 16 | Steroids, IVIg, plasma exchange | 5 | 5 | No |
| 5 | Negative | 21 | Steroids, IVIg | 3 | 3 | No |
| 6 | Negative | 18 | Steroids, IVIg | 3 | 3 | No |
| 7 | Negative | 10 | Steroids, IVIg | 3 | 3 | No |
| 8 | Negative | 18 | Steroids, IVIg | 4 | 4 | No |